This document discusses advances in cancer diagnosis and treatment. It covers new diagnostic techniques like advanced pathology using techniques like IHC, FISH, and genomic assays that provide more molecular information about tumors. Imaging techniques like PET scans are now able to more precisely define tumors and monitor treatment response. The document also discusses the shifting treatment paradigm towards personalized and targeted therapies that act on specific molecular pathways identified as disrupted in a patient's cancer. Several new targeted drugs approved in recent years are mentioned along with the biomarkers they target like HER2, BCR-ABL, MEK, PI3K, VEGF receptors.